Affordable inactivated poliovirus vaccine: strategies and progress.
about
Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human DiseasesCharacterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccAdjuvants in micro- to nanoscale: current state and future direction.Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.Immunogenicity of antigen-conjugated biodegradable polydiacetylene liposomes administered mucosally.Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles.Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV).
P2860
Q33870122-36DF25A6-C907-4DFF-8D35-96E681216582Q35968325-56E08EF9-412A-46CF-8E8D-1D8AA6568A8BQ36616041-45426920-A2D6-4780-BB9F-3E2E2E898DEDQ37542082-9953BFCD-9E73-494E-A10D-B51C6B77FAE9Q37607884-430FFE63-643F-426E-92CE-116ACE0BD1C2Q38520210-6B82AAB8-7D1D-4120-92C2-1643A3C12DDBQ38609795-A44EDBCB-7FEF-4343-BCC9-918A06169E12Q38796753-4ED89CC2-15BB-4ACA-AA9B-6AAF44B6D70AQ39280954-44D1D194-2669-40FC-8EF8-83F84E21E7E6Q39393782-53D7E8F9-D567-43C2-85D3-BBC8223D9F47Q40563756-B6983CFE-136E-47D0-AFC5-44847E8800AAQ40694023-E67E1F8E-1088-46E9-9CE4-D09821B44A06Q52619302-FA74ED37-95CA-43AA-9EDC-9808E9FEBB4B
P2860
Affordable inactivated poliovirus vaccine: strategies and progress.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Affordable inactivated poliovirus vaccine: strategies and progress.
@en
type
label
Affordable inactivated poliovirus vaccine: strategies and progress.
@en
prefLabel
Affordable inactivated poliovirus vaccine: strategies and progress.
@en
P2093
P2860
P356
P1476
Affordable inactivated poliovirus vaccine: strategies and progress.
@en
P2093
Hamid S Jafari
Hiromasa Okayasu
Marina Takane
R Bruce Aylward
Roland W Sutter
P2860
P304
P356
10.1093/INFDIS/JIU128
P407
P478
210 Suppl 1
P577
2014-11-01T00:00:00Z